Kaplan–Meier analysis of the overall survival (OS) rates showed that the OS rates for the low-expression group (PKD1-low) were significantly higher than those for the high-expression group (PKD1-high) (p < 0.001) in low-grade gliomas (Figure 3a). The gene discussed is PKD1; the disease is central nervous system cancer.